AMLX CIK: 1658551

Amylyx Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−74.8
FY22:
−180
FY23:
11.9
FY24:
−168
FY25:
−123
Change from FY21 to FY25
millions USD
FY21:
−46.4
FY22:
−239
FY23:
92.1
FY24:
75.7
FY25:
14.0
Change from FY21 to FY25
millions USD
FY21:
159
FY22:
432
FY23:
3.54
FY24:
0.35
FY25:
257
millions USD
FY21:
37.3
FY22:
12.9
FY23:
108
FY24:
−92.1
FY25:
149
(positive)
Change from FY21 to FY25
millions USD
FY21:
−75.2
FY22:
−182
FY23:
10.7
FY24:
−168
FY25:
−123

All amounts in millions USD Data source:SEC EDGAR